Aspirin-Sensitive Asthma
作者： Andrzej Szczeklik , Ewa Nizankowska-Mogilnicka , Marek Sanak
DOI: 10.1007/978-4-431-88317-3_17
关键词:
摘要: Most people tolerate aspirin and other nonsteroidal anti-inflammatory drugs (NSAID) well. Asthmatics, however, are exception. First reports on the attacks of bronchoconstriction following ingestion appeared over a hundred years ago, shortly after introduction into therapy. It took several decades to realize that aspirin-induced asthma (AIA), as it started be addressed, constitutes clearcut clinical syndrome. Some mechanisms operating in syndrome have been clarified, but its origin still awaits explanation. Within last few reviews AIA were published [1–5]. In this paper we, therefore, concentrate most recent findings, presentation basic data.
springer.com
sci-hub.st 参考文章(104)
A. Szczeklik, E. Nizankowska-Mogilnicka, M. Sanak, Hypersensitivity to Aspirin and Other NSAIDs: Mechanisms, Clinical Presentation and Management Karger Publishers. pp. 340- 349 ,(2007) , 10.1159/000104211
H. Mita, S. Endoh, M. Kudoh, Y. Kawagishi, M. Kobayashi, M. Taniguchi, K. Akiyama, Possible involvement of mast‐cell activation in aspirin provocation of aspirin‐induced asthma Allergy. ,vol. 56, pp. 1061- 1067 ,(2008) , 10.1111/J.1398-9995.2001.00913.X
A. Szczeklik, E. Niżankowska, M. Duplaga, on behalf of the Aiane Investigators, Natural history of aspirin‐induced asthma European Respiratory Journal. ,vol. 16, pp. 432- 436 ,(2000) , 10.1034/J.1399-3003.2000.016003432.X
A Szczeklik, K Sladek, Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma European Respiratory Journal. ,vol. 6, pp. 391- 399 ,(1993)
Michael B. Levy, Jordan N. Fink, Anaphylaxis to celecoxib Annals of Allergy Asthma & Immunology. ,vol. 87, pp. 72- 73 ,(2001) , 10.1016/S1081-1206(10)62327-7
Haruhisa Mita, Naomi Turikisawa, Tetsuo Yamada, Masami Taniguchi, Quantification of leukotriene B4 glucuronide in human urine. Prostaglandins & Other Lipid Mediators. ,vol. 83, pp. 42- 49 ,(2007) , 10.1016/J.PROSTAGLANDINS.2006.09.010
M. Morais-Almeida, S. Marinho, S. Rosa, A. Gaspar, J. E. Rosado-Pinto, Multiple Drug Intolerance Including Etoricoxib Allergy. ,vol. 61, pp. 144- 145 ,(2006) , 10.1111/J.1398-9995.2005.00878.X
L. Mastalerz, E. Nizankowska, M. Sanak, F. Mejza, M. Pierzchalska, S. Bazan-Socha, A. Bestynska-Krypel, A. Cmiel, A. Szczeklik, Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist. European Journal of Clinical Investigation. ,vol. 32, pp. 949- 955 ,(2002) , 10.1046/J.1365-2362.2002.01088.X
H. Mita, N. Higashi, M. Taniguchi, A. Higashi, K. Akiyama, Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin‐intolerant asthma after intravenous aspirin challenge Clinical & Experimental Allergy. ,vol. 34, pp. 1262- 1269 ,(2004) , 10.1111/J.1365-2222.2004.02034.X
Pär Gyllfors, Grazyna Bochenek, John Overholt, Diane Drupka, Maria Kumlin, James Sheller, Ewa Nizankowska, Peter C. Isakson, Filip Mejza, James B. Lefkowith, Sven-Erik Dahlén, Andrew Szczeklik, John J. Murray, Barbro Dahlén, Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib Journal of Allergy and Clinical Immunology. ,vol. 111, pp. 1116- 1121 ,(2003) , 10.1067/MAI.2003.1450